These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14526391)

  • 1. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Am J Hum Genet; 2003 Nov; 73(5):1157-61. PubMed ID: 14526391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.
    Cravo M; Afonso AJ; Lage P; Albuquerque C; Maia L; Lacerda C; Fidalgo P; Chaves P; Cruz C; Nobre-Leitão C
    Gut; 2002 Mar; 50(3):405-12. PubMed ID: 11839723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.
    Trojan J; Zeuzem S; Randolph A; Hemmerle C; Brieger A; Raedle J; Plotz G; Jiricny J; Marra G
    Gastroenterology; 2002 Jan; 122(1):211-9. PubMed ID: 11781295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
    Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
    Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.
    Liu SR; Zhao B; Wang ZJ; Wan YL; Huang YT
    World J Gastroenterol; 2004 Sep; 10(18):2647-51. PubMed ID: 15309712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
    Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
    Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families].
    Cai Q; Sun MH; Fu G; Ding CW; Mo SJ; Cai SJ; Ren SX; Min DL; Xu XL; Zhu WP; Zhang TM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):323-8. PubMed ID: 14514376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization of Chinese hereditary non-polyposis colorectal cancer by DHPLC and multiplex PCR.
    Yuan Y; Huang YQ; Cai SR; Song YM; Zheng S; Zhang SZ
    Jpn J Clin Oncol; 2004 Nov; 34(11):660-6. PubMed ID: 15613555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs.
    Shotelersuk V; Desudchit T; Tongkobpetch S
    Int J Mol Med; 2004 Oct; 14(4):683-9. PubMed ID: 15375602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
    Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK
    Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family.
    McVety S; Li L; Gordon PH; Chong G; Foulkes WD
    J Med Genet; 2006 Feb; 43(2):153-6. PubMed ID: 15923275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
    Balogh GA; Russo IH; Russo J
    Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
    Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
    Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN
    Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations.
    Maliaka YK; Chudina AP; Belev NF; Alday P; Bochkov NP; Buerstedde JM
    Hum Genet; 1996 Feb; 97(2):251-5. PubMed ID: 8566964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
    Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
    Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients.
    Baudhuin LM; Ferber MJ; Winters JL; Steenblock KJ; Swanson RL; French AJ; Butz ML; Thibodeau SN
    Gastroenterology; 2005 Sep; 129(3):846-54. PubMed ID: 16143124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.